Press Releases

Date Title and Summary Additional Formats
Toggle Summary Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispensing Service to Enhance Medication Safety and Dispensing Efficiency
Combination of automation and technology-enabled services supports more cost-effective workflows and expanded distribution models MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 20, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for...
View HTML
Toggle Summary Omnicell Launches EnlivenHealth™ to Aid Retail Pharmacies and Health Plans In Improving Patient Adherence, Quality Measures, and Retention
The Industry-Leading Engagement and Digital Communication Solutions from EnlivenHealth Aim to Achieve Lifelong Optimal Health for Patient Populations MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 6, 2020-- Omnicell, Inc. , (NASDAQ:OMCL), a leading provider of medication management solutions and...
View HTML
Toggle Summary Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Expands pharmacy inventory management capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to...
View HTML
Toggle Summary Omnicell to Release Third Quarter 2020 Earnings Results on October 27, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 29, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020 , to discuss the Company’s Third Quarter...
View HTML
Toggle Summary Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 23, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25% Convertible Senior...
View HTML
Toggle Summary Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 22, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors, $500.0...
View HTML
Toggle Summary Omnicell to Present at Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 1, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual Healthcare...
View HTML
Toggle Summary Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding
Combination of technology, services, and data supports more cost-effective workflows MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Aug. 17, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced...
View HTML
Toggle Summary Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to non-GAAP...
View HTML
Toggle Summary Omnicell Reports Second Quarter 2020 Results
GAAP revenues of $199.6 million and net loss per diluted share of $0.10 Non-GAAP revenues $199.6 million and net income per diluted share of $0.37 Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 28, 2020-- Omnicell, Inc....
View HTML